Patel Sanjiv 4
4 · Relay Therapeutics, Inc. · Filed Jan 14, 2025
Insider Transaction Report
Form 4
Patel Sanjiv
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-01-10+1,105,000→ 1,105,000 totalExercise: $4.45Exp: 2035-01-09→ Common Stock (1,105,000 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 10, 2025, subject to the reporting person's continued service with the Issuer through each vesting date.